Targeting reactive oxygen species in hypertension

Area of Science:

• Cardiovascular Research
• Oxidative Stress Biology
• Pharmacology

Background:

• Hypertension significantly elevates the risk of vascular diseases like stroke and myocardial infarction.
• Increased reactive oxygen species (ROS) during hypertension contribute to vascular damage.
• NADPH oxidase is identified as a primary source of cardiovascular ROS, making it a therapeutic target.

Purpose of the Study:

• To review the role of reactive oxygen species in hypertension-induced vascular disease.
• To explore therapeutic strategies targeting NADPH oxidase for hypertension and end-organ damage.
• To present novel peptidic inhibitors of NADPH oxidase homologues.

Main Methods:

• Development of cell-permeant peptidic inhibitors.
• Targeting specific interactions within NAD(P)H oxidase homologues, such as nox2 and p47-phox.
• Evaluation of inhibitors in preclinical models for effects on neoplasia and hypertrophy.

Main Results:

• Reactive oxygen species scavengers and inhibitors have been investigated for hypertension.
• Specificity of existing ROS inhibitors is a significant concern.
• Novel peptidic inhibitors targeting NAD(P)H oxidase interactions show promise in preclinical studies, reducing neoplasia and hypertrophy.

Conclusions:

• Specific inhibition of NAD(P)H oxidase effectively reduces cardiovascular oxidative stress.
• New inhibitors targeting novel oxidase homologues are crucial for understanding their physiological roles.
• These novel inhibitors represent a promising avenue for developing new antioxidant therapies for hypertension.